SHAREHOLDER ALERT: Weiss Law Reminds LHCG, NLSN, GDNSF, and MSP Shareholders About Its Ongoing Investigations Psychedelics Investing
Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board Pharmaceutical Investing
KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th Pharmaceutical Investing
Seelos Therapeutics to Participate in the B. Riley Securities' Virtual Neuro and Ophthalmology Conference Psychedelics Investing
Universal Ibogaine Advises of Departure of Marilyn Loewen Mauritz from the Board of Directors Pharmaceutical Investing
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference Pharmaceutical Investing
NeonMind To Improve Patient Care and Data Management by Adopting Digital Platform for Ketamine Treatments in Preparation of Opening Its Inaugural Specialty Mental Health Clinic Psychedelics Investing
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers Psychedelics Investing
NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic Psychedelics Investing
